<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">healthcare</journal-id><journal-title-group><journal-title xml:lang="ru">Здравоохранение. Healthcare</journal-title><trans-title-group xml:lang="en"><trans-title>Healthcare</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1027-7218</issn><publisher><publisher-name>Republican Scientific and Practical Center for Medical Technologies, Informatization, Management and Health Economics</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">healthcare-59</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>Болезнь Виллебранда в детской гинекологии. Скрининг, клинические наблюдения</article-title><trans-title-group xml:lang="en"><trans-title>Von Willebrand disease in children’s gynecology. Screening, clinical observations</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Милош</surname><given-names>Т. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Milosh</surname><given-names>T.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Милош Татьяна Сергеевна — к. м. н., доцент кафедры акушерства и гинекологии</p><p>ул. Горького, 80, 230009, г. Гродно</p><p>сл. тел. +375 152 43-16-21</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Гродненский государственный медицинский университет</institution><country>Belarus</country></aff><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>23</day><month>09</month><year>2025</year></pub-date><volume>0</volume><issue>2</issue><fpage>4</fpage><lpage>15</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Милош Т.С., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Милош Т.С.</copyright-holder><copyright-holder xml:lang="en">Milosh T.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://healthcare.ejournal.by/jour/article/view/59">https://healthcare.ejournal.by/jour/article/view/59</self-uri><abstract><p>Описываются клинические случаи течения болезни Виллебранда у девочек. Это нарушение системы гемостаза — вариант наиболее распространенной наследственной геморрагической гемостазиопатии. В связи с этим крайне важным аспектом является ранний диагностический скрининг данной патологии как на амбулаторном этапе, так и в стационаре. Оценка индекса кровоточивости с использованием балльной шкалы тяжести геморрагического синдрома наряду с методами анализа менструальной кровопотери способствует своевременному выявлению болезни Виллебранда и других коагулопатий у девочек и женщин в Республике Беларусь. Это позволяет не только обеспечить медицинскую профилактику и терапию, но и значительно снизить риск жизнеугрожающих кровотечений у данных пациенток. Представлены два клинических случая с детальным описанием клинико-анамнестической картины и тактики.</p></abstract><trans-abstract xml:lang="en"><p>The paper describes cases of the clinical course and management of girls with von Willebrand disease. This hemostatic disorder is a variant of the most common hereditary hemorrhagic hemostasiopathies. Therefore, early diagnostic screening for this pathology in both outpatient and inpatient settings is critically important. The analysis of bleeding index using a point-based scale to assess the severity of hemorrhagic syndrome, along with methods for evaluating menstrual blood loss, enables timely detection of von Willebrand disease and other coagulopathies in girls and women in the Republic of Belarus. This approach ensures appropriate medical prevention and treatment, thereby reducing the risk of life-threatening bleeding in these patients. Two clinical cases are presented with detailed descriptions of the clinical, anamnestic, and tactical aspects.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>наследственные коагулопатии</kwd><kwd>болезнь Виллебранда</kwd><kwd>геморрагический синдром</kwd><kwd>скрининг</kwd><kwd>девочки</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hereditary coagulopathies</kwd><kwd>von Willebrand disease</kwd><kwd>hemorrhagic syndrome</kwd><kwd>screening</kwd><kwd>girls</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Rodeghiero, F. Epidemiological investigation of the prevalence of von Willebrand disease / F. Rodeghiero, G. Castaman, E. Dini // Blood. — 1987. — Vol. 69, № 2. — Р. 454—459.</mixed-citation><mixed-citation xml:lang="en">Rodeghiero, F. Epidemiological investigation of the prevalence of von Willebrand disease / F. Rodeghiero, G. Castaman, E. Dini // Blood. — 1987. — Vol. 69, № 2. — Р. 454—459.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Update on the pathophysiology and classification of von Willebrand disease : a report of the Subcommittee on von Willebrand Factor / J. E. Sadler, U. Budde, J. C. J. Eikenboom [et al.] ; Working Party on von Willebrand Disease Classification // Journal of Thrombosis and Haemostasis. — 2006. — Vol. 4, iss. 10. — Р. 2103—2114.</mixed-citation><mixed-citation xml:lang="en">Update on the pathophysiology and classification of von Willebrand disease : a report of the Subcommittee on von Willebrand Factor / J. E. Sadler, U. Budde, J. C. J. Eikenboom [et al.] ; Working Party on von Willebrand Disease Classification // Journal of Thrombosis and Haemostasis. — 2006. — Vol. 4, iss. 10. — Р. 2103—2114.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Von Willebrand disease (VWD) : evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panelreport (USA) / W. L. Nichols, M. B. Hultin, A. H. James [et al.] // Haemophilia. — 2008. — Vol. 14, iss. 2. — Р. 171—232.</mixed-citation><mixed-citation xml:lang="en">Von Willebrand disease (VWD) : evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panelreport (USA) / W. L. Nichols, M. B. Hultin, A. H. James [et al.] // Haemophilia. — 2008. — Vol. 14, iss. 2. — Р. 171—232.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease / P. D. James, N. T. Connell, B. Ameer [et al.] // Blood Advances. — 2021. — Vol. 5, iss. 1. — Р. 280—300.</mixed-citation><mixed-citation xml:lang="en">ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease / P. D. James, N. T. Connell, B. Ameer [et al.] // Blood Advances. — 2021. — Vol. 5, iss. 1. — Р. 280—300.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Seidizadeh, O. Von Willebrand disease type 2N: an update / O. Seidizadeh, F. Peyvandi, P. M. Mannucci // Journal of Thrombosis and Haemostasis. — 2021. — Vol. 19, iss. 4. — Р. 909—916.</mixed-citation><mixed-citation xml:lang="en">Seidizadeh, O. Von Willebrand disease type 2N: an update / O. Seidizadeh, F. Peyvandi, P. M. Mannucci // Journal of Thrombosis and Haemostasis. — 2021. — Vol. 19, iss. 4. — Р. 909—916.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel / A. H. James, P. A. Kouides, R. Abdul-Kadir [et al.] // American Journal of Obstetrics &amp; Gynecology. — 2009. — Vol. 201, iss. 1. — DOI: 10.1016/j.ajog.2009.04.024.</mixed-citation><mixed-citation xml:lang="en">Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel / A. H. James, P. A. Kouides, R. Abdul-Kadir [et al.] // American Journal of Obstetrics &amp; Gynecology. — 2009. — Vol. 201, iss. 1. — DOI: 10.1016/j.ajog.2009.04.024.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Кабаева, Е. Н. Роль клинического опроса с использованием шкалы риска геморрагического синдрома в диагностике болезни Виллебранда / Е. Н. Кабаева // Репродуктивное здоровье. Восточная Европа. — 2023. — Т. 13, № 3. — С. 212—223.</mixed-citation><mixed-citation xml:lang="en">Кабаева, Е. Н. Роль клинического опроса с использованием шкалы риска геморрагического синдрома в диагностике болезни Виллебранда / Е. Н. Кабаева // Репродуктивное здоровье. Восточная Европа. — 2023. — Т. 13, № 3. — С. 212—223.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Von Willebrand Disease Epidemiology, Burden of Illness and Management : a systematic review / P. Du, A. Bergamasco, Y. Moride [et al.] // Journal of Blood Medicine. — 2023. — Vol. 14. — Р. 189—208.</mixed-citation><mixed-citation xml:lang="en">Von Willebrand Disease Epidemiology, Burden of Illness and Management : a systematic review / P. Du, A. Bergamasco, Y. Moride [et al.] // Journal of Blood Medicine. — 2023. — Vol. 14. — Р. 189—208.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">James, A. H. More than menorrhagia: a review of the obstetric and gynaecological manifestations of bleeding disorders / A. H. James // Haemophilia. — 2005 — Vol. 11, iss. 4. — Р. 295—307.</mixed-citation><mixed-citation xml:lang="en">James, A. H. More than menorrhagia: a review of the obstetric and gynaecological manifestations of bleeding disorders / A. H. James // Haemophilia. — 2005 — Vol. 11, iss. 4. — Р. 295—307.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Heavy menstrual bleeding: assessment and management. — London : NICE, 2021. — URL: https:// pubmed.ncbi.nlm.nih.gov/29634173/ (date of access: 10.10.2024).</mixed-citation><mixed-citation xml:lang="en">Heavy menstrual bleeding: assessment and management. — London : NICE, 2021. — URL: https:// pubmed.ncbi.nlm.nih.gov/29634173/ (date of access: 10.10.2024).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Bleeding disorders in teenagers presenting with menorrhagia / Y. Jayasinghe, P. Moore, S. Donath [et al.] // Australian and New Zealand Journal of Obstetrics and Gynaecology. — 2005. — Vol. 45, № 5. — Р. 439—443.</mixed-citation><mixed-citation xml:lang="en">Bleeding disorders in teenagers presenting with menorrhagia / Y. Jayasinghe, P. Moore, S. Donath [et al.] // Australian and New Zealand Journal of Obstetrics and Gynaecology. — 2005. — Vol. 45, № 5. — Р. 439—443.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Jain, V. Contemporary evaluation of women and girls with abnormal uterine bleeding: FIGO Systems 1 and 2 / V. Jain, M. G. Munro, H. O. D. Critchley // International Journal of Gynecology &amp; Obstetrics. — 2023. — Vol. 162, iss. S2. — Р. 29—42.</mixed-citation><mixed-citation xml:lang="en">Jain, V. Contemporary evaluation of women and girls with abnormal uterine bleeding: FIGO Systems 1 and 2 / V. Jain, M. G. Munro, H. O. D. Critchley // International Journal of Gynecology &amp; Obstetrics. — 2023. — Vol. 162, iss. S2. — Р. 29—42.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Munro, M. G. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years : 2018 revisions / M. G. Munro, H. O. D. Critchley, I. S. Fraser ; FIGO Menstrual Disorders Committee // International Journal of Gynecology &amp; Obstetrics. — 2018. — Vol. 143, iss. 3. — Р. 393—408.</mixed-citation><mixed-citation xml:lang="en">Munro, M. G. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years : 2018 revisions / M. G. Munro, H. O. D. Critchley, I. S. Fraser ; FIGO Menstrual Disorders Committee // International Journal of Gynecology &amp; Obstetrics. — 2018. — Vol. 143, iss. 3. — Р. 393—408.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Diagnosis and treatment of von Willebrand disease in 2024 and beyond / P. James [et al.] // Haemophilia. — 2024. — Vol. 30, iss. S2. — Р. 103—111.</mixed-citation><mixed-citation xml:lang="en">Diagnosis and treatment of von Willebrand disease in 2024 and beyond / P. James [et al.] // Haemophilia. — 2024. — Vol. 30, iss. S2. — Р. 103—111.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Castaman, G. Principles of care for diagnosis and treatment of von Willebrand disease / G. Castaman, A. Goodeve, J. Eikenboom // Haematologica. — 2013. — Vol. 98, № 5. — Р. 667—674.</mixed-citation><mixed-citation xml:lang="en">Castaman, G. Principles of care for diagnosis and treatment of von Willebrand disease / G. Castaman, A. Goodeve, J. Eikenboom // Haematologica. — 2013. — Vol. 98, № 5. — Р. 667—674.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Yee, A. Von Willebrand factor: form for function / A. Yee, C. A. Kretz // Seminars in Thrombosis and Hemostasis. — 2014. — Vol. 40, № 1. — Р. 17—27.</mixed-citation><mixed-citation xml:lang="en">Yee, A. Von Willebrand factor: form for function / A. Yee, C. A. Kretz // Seminars in Thrombosis and Hemostasis. — 2014. — Vol. 40, № 1. — Р. 17—27.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">The difficult journey to treatment for women suffering from heavy menstrual bleeding: a multinational survey / A. L. da Silva Filho, C. Caetano, A. Lahav [et al.] // The European Journal of Contraception &amp; Reproductive Health Care. — 2021. — Vol. 26, iss. 5. — Р. 390—398.</mixed-citation><mixed-citation xml:lang="en">The difficult journey to treatment for women suffering from heavy menstrual bleeding: a multinational survey / A. L. da Silva Filho, C. Caetano, A. Lahav [et al.] // The European Journal of Contraception &amp; Reproductive Health Care. — 2021. — Vol. 26, iss. 5. — Р. 390—398.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">From menarche to menopause, heavy menstrual bleeding is the underrated compass in reproductive health / S. Vannuccini, V. Jain, H. Critchley [et al.] // Fertility and Sterility. — 2022. — Vol. 118, iss. 4. — Р. 625—636.</mixed-citation><mixed-citation xml:lang="en">From menarche to menopause, heavy menstrual bleeding is the underrated compass in reproductive health / S. Vannuccini, V. Jain, H. Critchley [et al.] // Fertility and Sterility. — 2022. — Vol. 118, iss. 4. — Р. 625—636.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Оказание медицинской помощи пациентам (взрослое и детское население) с гемофилией А и гемофилией В. Оказание медицинской помощи пациентам (взрослое и детское население) с болезнью Виллебранда : клин. протоколы : постановление Министерства здравоохранения Респ. Беларусь, 29 июля 2022 г., № 80 // Нац. правовой Интернет-портал Респ. Беларусь. — URL: https://minzdrav.gov.by (дата обращения: 20.10.2022).</mixed-citation><mixed-citation xml:lang="en">Оказание медицинской помощи пациентам (взрослое и детское население) с гемофилией А и гемофилией В. Оказание медицинской помощи пациентам (взрослое и детское население) с болезнью Виллебранда : клин. протоколы : постановление Министерства здравоохранения Респ. Беларусь, 29 июля 2022 г., № 80 // Нац. правовой Интернет-портал Респ. Беларусь. — URL: https://minzdrav.gov.by (дата обращения: 20.10.2022).</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">A pocket guide to the diagnosis, evaluation, and management of von Willebrand disease / National Heart, Lung, and Blood Institute VWD Expert Panel. — February, 2008. — URL: https://www.nhlbi.nih.gov/sites/default/files/publications/08-5833.pdf (date of access: 10.10.2024).</mixed-citation><mixed-citation xml:lang="en">A pocket guide to the diagnosis, evaluation, and management of von Willebrand disease / National Heart, Lung, and Blood Institute VWD Expert Panel. — February, 2008. — URL: https://www.nhlbi.nih.gov/sites/default/files/publications/08-5833.pdf (date of access: 10.10.2024).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
